We are live on
!
Find out more
RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$810M
1-Year Est. Return
30.2%
This Fund
S&P 500
This Quarter
Est. Return
+6.63%
1 Year Est. Return
+30.2%
3 Year Est. Return
+116.38%
5 Year Est. Return
+153.13%
10 Year Est. Return
+962.25%
AUM
$256M
AUM Growth
–
Cap. Flow
+$245M
Cap. Flow
% of AUM
96.01%
Top 10 Holdings %
Top 10 Hldgs %
29.36%
Holding
84
New
84
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$10.6M |
| 2 |
CELG
Celgene Corp
CELG
|
+$7.75M |
| 3 |
Gilead Sciences
GILD
|
+$7.59M |
| 4 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$7.28M |
| 5 |
Biogen
BIIB
|
+$6.98M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 82.65% |
| 2 | Financials | 1.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
COV
26
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $3.06M | 1.2% |
+45,000
| New | +$2.93M |
|
27
Elevance Health
ELV
$85.5B
| $2.96M | 1.16% |
+32,000
| New | +$2.84M |
|
|
INFI
28
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $2.9M | 1.13% |
+210,000
| New | +$2.97M |
|
29
Cencora
COR
$61.2B
| $2.81M | 1.1% |
+40,000
| New | +$2.69M |
|
30
Zimmer Biomet
ZBH
$18.4B
| $2.8M | 1.09% |
+30,900
| New | +$2.67M |
|
31
Thermo Fisher Scientific
TMO
$220B
| $2.78M | 1.09% |
+25,000
| New | +$2.49M |
|
32
Insulet
PODD
$9.79B
| $2.78M | 1.09% |
+75,000
| New | +$2.77M |
|
|
AGN
33
DELISTED
Allergan Inc
AGN
| $2.78M | 1.09% |
+25,000
| New | +$2.39M |
|
34
Becton Dickinson
BDX
$48.2B
| $2.76M | 1.08% |
+25,625
| New | +$2.66M |
|
35
Johnson & Johnson
JNJ
$625B
| $2.75M | 1.07% |
+30,000
| New | +$2.76M |
|
|
THOR
36
DELISTED
THORATEC CORPORATION
THOR
| $2.75M | 1.07% |
+75,000
| New | +$2.94M |
|
|
DVAX
37
DELISTED
Dynavax Technologies
DVAX
| $2.74M | 1.07% |
+140,000
| New | +$2.05M |
|
|
AET
38
DELISTED
Aetna Inc
AET
| $2.74M | 1.07% |
+40,000
| New | +$2.61M |
|
39
DexCom
DXCM
$32B
| $2.73M | 1.07% |
+308,000
| New | +$2.44M |
|
|
VAR
40
DELISTED
Varian Medical Systems, Inc.
VAR
| $2.72M | 1.06% |
+39,913
| New | +$2.66M |
|
41
HCA Healthcare
HCA
$89.5B
| $2.62M | 1.03% |
+55,000
| New | +$2.54M |
|
|
PRXL
42
DELISTED
Parexel International Corp
PRXL
| $2.62M | 1.02% |
+58,000
| New | +$2.65M |
|
|
CYBX
43
DELISTED
CYBERONICS INC
CYBX
| $2.62M | 1.02% |
+40,000
| New | +$2.43M |
|
44
Teva Pharmaceuticals
TEVA
$41.2B
| $2.6M | 1.02% |
+65,000
| New | +$2.56M |
|
45
Baxter International
BAX
$14.2B
| $2.57M | 1.01% |
+68,117
| New | +$2.47M |
|
|
STJ
46
DELISTED
St Jude Medical
STJ
| $2.48M | 0.97% |
+40,000
| New | +$2.32M |
|
47
Cigna
CI
$74.6B
| $2.36M | 0.92% |
+27,000
| New | +$2.21M |
|
48
Agilent Technologies
A
$41.2B
| $2.29M | 0.89% |
+55,920
| New | +$2.13M |
|
|
OCR
49
DELISTED
OMNICARE INC
OCR
| $2.23M | 0.87% |
+37,000
| New | +$2.12M |
|
|
HPTX
50
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
| $2.22M | 0.87% |
+110,000
| New | +$2.59M |
|
Similar funds
PS
ACM
AR
KCP
BCM
RIM
GCM
CL
Rhenman & Partners Asset Management's Q4 2013 Portfolio in Review
Q4 2013 is the first quarter with a 13F filing on record for Rhenman & Partners Asset Management, which disclosed 84 positions worth $256M. Its ten largest holdings account for 29% of the portfolio.
Its largest position is Regeneron Pharmaceuticals: 37,000 shares worth $10.2M.
By sector, the portfolio is most concentrated in Healthcare at 83% of assets, followed by Financials.
- Rhenman & Partners Asset Management's largest Q4 2013 buy was Regeneron Pharmaceuticals: 37,000 shares worth $10.2M.
- Rhenman & Partners Asset Management's ten largest holdings make up 29% of its $256M portfolio in Q4 2013.
- Rhenman & Partners Asset Management disclosed 84 positions in Q4 2013, its first 13F filing on record.
Based on Rhenman & Partners Asset Management's 13F filing for Q4 2013, filed 14 Feb 2014.